129 related articles for article (PubMed ID: 1125725)
1. Hydroxyproline excretion in patients with breast cancer and response to treatment.
Powles TJ; Leese CL; Bondy PK
Br Med J; 1975 Apr; 2(5964):164-6. PubMed ID: 1125725
[TBL] [Abstract][Full Text] [Related]
2. Early morning hydroxyproline excretion in patients with breast cancer.
Powles TJ; Rosset G; Leese CL; Bondy PK
Cancer; 1976 Dec; 38(6):2564-6. PubMed ID: 1000483
[TBL] [Abstract][Full Text] [Related]
3. Relevance of hydroxyproline excretion to bone metastasis in breast cancer.
Gielen F; Dequeker J; Drochmans A; Wildiers J; Merlevede M
Br J Cancer; 1976 Sep; 34(3):279-85. PubMed ID: 974001
[TBL] [Abstract][Full Text] [Related]
4. [Urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast cancer].
Ditzel J; Jordal R; Riskoer N
Ugeskr Laeger; 1968 Oct; 130(42):1766-71. PubMed ID: 5724711
[No Abstract] [Full Text] [Related]
5. Urinary hydroxyproline excretion in patients with breast cancer.
Cuschieri A; Felgate R
Br J Surg; 1971 Nov; 58(11):862. PubMed ID: 5124876
[No Abstract] [Full Text] [Related]
6. [Hydroxyproline in the diagnosis of bone metastases in breast cancer].
Gasser AB; Depierre D; Alberto P; Courvoisier B
Schweiz Med Wochenschr; 1977 Jul; 107(28):984-6. PubMed ID: 897640
[TBL] [Abstract][Full Text] [Related]
7. Urinary hydroxyproline excretion in carcinoma of the breast.
Cuschieri A; Felgate RA
Br J Exp Pathol; 1972 Jun; 53(3):237-41. PubMed ID: 5055709
[TBL] [Abstract][Full Text] [Related]
8. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
Ditzel J; Jordal R; Riskaer N
Acta Endocrinol (Copenh); 1968 Nov; 59(3):353-61. PubMed ID: 5754976
[No Abstract] [Full Text] [Related]
9. Urinary hydroxyproline excretion in patients with cancer.
Guzzo CE; Pachas WN; Pinals RS; Krant MJ
Cancer; 1969 Aug; 24(2):382-7. PubMed ID: 5796782
[No Abstract] [Full Text] [Related]
10. [Hydroxyproline excretion as an index for the evaluation of metabolic bone changes].
Mühlbach R
Beitr Orthop Traumatol; 1966 Oct; 13(10):606-8. PubMed ID: 5977397
[No Abstract] [Full Text] [Related]
11. Urinary hydroxyproline excretion in early and advanced breast cancer-a sequential study.
Cuschieri A
Br J Surg; 1973 Oct; 60(10):800-3. PubMed ID: 4748385
[No Abstract] [Full Text] [Related]
12. [Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases].
Polico C; Nascimben O; Maccari F; Fazzin G
Quad Sclavo Diagn; 1978 Dec; 14(4):486-93. PubMed ID: 757622
[TBL] [Abstract][Full Text] [Related]
13. Postabsorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer.
Niell HB; Palmieri GM; Neely CL; McDonald MW
Arch Intern Med; 1981 Oct; 141(11):1471-3. PubMed ID: 7283558
[TBL] [Abstract][Full Text] [Related]
14. Circadian rhythm of total urinary hydroxyproline excretion and 3-H hydroxyproline test.
Radom S; Zulawski M; Dahlig E
Clin Chim Acta; 1972 Jun; 39(1):277-8. PubMed ID: 4556834
[No Abstract] [Full Text] [Related]
15. Urinary hydroxyproline in the management of breast cancer.
Cuschieri A
World J Surg; 1977 May; 1(3):299-302. PubMed ID: 883324
[No Abstract] [Full Text] [Related]
16. 'Early' breast cancer, bone scanning, and the urinary excretion of hydroxyproline.
Sumner DS; Baum M; Parsons V; Edwards MH
Br J Surg; 1973 Apr; 60(4):306. PubMed ID: 4700234
[No Abstract] [Full Text] [Related]
17. Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.
Gasser AB; Depierre D; Mermillod B; Courvoisier B
Br J Cancer; 1982 Mar; 45(3):477-81. PubMed ID: 7041941
[No Abstract] [Full Text] [Related]
18. [Hydroxyprolinuria in relation to bone metastases in patients with breast cancer].
Rico Lenza H; Millán Núñez-Cortés J; Rodríguez Mora VI; Espinós Pérez D
Rev Esp Oncol; 1980; 27(1):61-6. PubMed ID: 7209108
[TBL] [Abstract][Full Text] [Related]
19. [Urinary hydroxyproline in advanced breast carcinoma and response to treatment with medroxyprogesterone acetate (MAP) in high doses].
Martoni A; Pedelini G; Colalongo G; Biagi R; Mambelli M; Jafelice G; Rocchetta G; Piana E; Pannuti F
Minerva Med; 1980 Sep; 71(31):2215-9. PubMed ID: 7422143
[TBL] [Abstract][Full Text] [Related]
20. The significance of hydroxyprolinuia for the proof of bone metastases of tumours.
Mirejovská E; Beska F; Pitronová M
Neoplasma; 1968; 15(4):433-8. PubMed ID: 5684467
[No Abstract] [Full Text] [Related]
[Next] [New Search]